Charles River Labs Intl sell CLSA
Start price
18.11.24
/
50%
€177.05
Target price
18.11.25
€155.14
Performance (%)
-21.21%
End price
19.11.25
€139.50
Summary
This prediction ended on 19.11.25 with a price of €139.50. The price of Charles River Labs Intl decreased from the start of the prediction. Compared to the start price this resulted in a performance of -21.21%. CLSA has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Charles River Labs Intl | 10.228% | 10.228% | 27.704% |
| iShares Core DAX® | 0.224% | 1.487% | 3.575% |
| iShares Nasdaq 100 | 6.047% | 16.188% | 39.144% |
| iShares Nikkei 225® | 5.724% | 11.690% | 50.962% |
| iShares S&P 500 | 2.172% | 8.056% | 25.618% |
Comments by CLSA for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International, Inc. (NYSE: CRL) was downgraded by analysts at CLSA from a "hold" rating to an "underperform" rating. They now have a $164.00 price target on the stock.
Ratings data for CRL provided by MarketBeat
In the thread Trading Charles River Labs Intl
Die von CLSA gewählte maximale Laufzeit wurde überschritten